|
Individuals diagnosed with Type 2 diabetes are at double the risk of having a stroke compared to those without diabetes, according to new research from the University of Alberta. It was found that the risk of a stroke is considered high within the first |
|
In a study appearing this month in the Journal of Immunology, researchers at the University of Illinois describe how an impaired anti-inflammatory response plays a role in the pathology of type 2 diabetes.
|
|
New data presented today at the Annual European Society of Hypertension meeting in Milan reveals that the long-acting angiotensin receptor blocker (ARB) telmisartan (MICARDIS®) may slow the progression of diabetic nephropathy in hypertensive type 2 d |
|
Weill Cornell Medical College has announced that it is the recipient of 0 million, made up of several major gifts, bringing the prestigious Medical College to the halfway mark in just the first seven months of its .3 billion capital campaign -- "Dis |
|
On June 5, 2007, the New England Journal of Medicine published results of an
interim analysis of the cardiovascular safety trial of rosiglitazone (brand name, Avandia). The article was
accompanied by three editorials. Although the findings from RECORD |
|
Men and women with diabetes at age 50 and older appear not to live as long overall, or have as many years without cardiovascular disease, than individuals without diabetes, according to a report in the June 11 issue of Archives of Internal Medicine, one |
